Cancer Science Institute of Singapore
Professor Daniel Tenen moved to Singapore in 2008 to lead the Cancer Science Institute of Singapore (CSI Singapore), with the aim of developing CSI Singapore into one of the world’s leading centers for cancer research by establishing and integrating key capabilities in cancer stem cells, cancer biology, and experimental therapeutics.
Professor Tenen is a leader in the field of gene regulation in normal cells and cancer. His research contributions have included establishing the role of transcription factors in differentiation of myeloid cells and the role of disruption of these pathways in leukemia and lung cancer. Recent studies focus on noncoding RNAs, including antisense RNAs, RNA editing, and noncoding RNAs in gene regulation, methylation, and cancer.